Effectiveness and Tolerability of Transdermal Rivastigmine in the Treatment of Alzheimer’s Disease in Daily Practice

Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s29116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Liposome Delivery Systems for the Treatment of Alzheimer’s Disease

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Update on the Use of Memantine in Alzheimer’s Disease

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2009English

Cytological and Cytometric Analysis of Oral Mucosa in Patients With Alzheimer’s and Parkinson’s Disease

Neuropsychiatric Disease and Treatment
2018English

Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer’s Disease

2020English

Associations of Alzheimer Rsquo S Disease With Macular Degeneration

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Altered Diastolic Function and Aortic Stiffness in Alzheimer’s Disease

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2014English

Disease Progression Model for Clinical Dementia Rating–Sum of Boxes in Mild Cognitive Impairment and Alzheimer’s Subjects From the Alzheimer’s Disease Neuroimaging Initiative

Neuropsychiatric Disease and Treatment
2014English

Pharmacokinetics of a Novel Transdermal Rivastigmine Patch for the Treatment of Alzheimer’s Disease: A Review

International Journal of Clinical Practice
Medicine
2009English

A Review of the Potential Therapeutic Role of Statins in the Treatment of Alzheimer’s Disease: Current Research and Opinion

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy